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Abstract
The liver is a complex organ that requires constant perfusion for the delivery 
of nutrients and oxygen and the removal of waste in order to survive. Efforts to 
recreate or mimic the liver microstructure via a ground-up approach are essential 
for liver tissue engineering. A decellularization/recellularization strategy is one 
of the approaches aiming at the possibility of producing a fully functional organ 
with in vitro-developed construction for clinical applications to replace failed 
livers, such as end-stage liver disease (ESLD). However, the complexity of the liver 
microarchitecture along with the limited suitable hepatic component, such as the 
optimization of the extracellular matrix (ECM) of the biomaterials, the selection 
of the seed cells, and development of the liver-specific three-dimensional (3D) 
niche settings, pose numerous challenges. In this chapter, we have provided a 
comprehensive outlook on how the physiological, pathological, and spatiotemporal 
aspects of these drawbacks can be turned into the current challenges in the field, 
and put forward a few techniques with the potential to address these challenges, 
mainly focusing on a decellularization-based liver regeneration strategy. We 
hypothesize the primary concepts necessary for constructing tissue-engineered 
liver organs based on either an intact (from a naïve liver) or a partial (from a 
pretreated liver) structure via simulating the natural development and regenera-
tive processes.
Keywords: tissue engineering, decellularization, recellularization, thrombogenicity, 
hemocompatibility, partial hepatectomy transplantation
1. Introduction
The liver is the largest internal organ in the human body, accounting for approx-
imately 2–5% of the total body volume [1, 2]. Physiologically, the liver possesses 
over 500 different functions [3] and any severe damage could be life-threatening, 
such as that caused by ESLD, including acute liver failure and chronic liver disease.
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In modern times, the failure of solid organs, such as ESLD caused by injury or 
disease, has become a major challenge in clinics [4]. According to the U.S. Centers 
for Disease Control and Prevention (https://www.cdc.gov/), in 2014, 38,170 people 
died of ESLD. Currently, orthotopic liver transplant (OLT) is an ideal therapy for 
ESLD. However, a shortage of liver organ donors severely limits OLT usage. The 
Department of Health and Human Services in the United States has estimated that 
(https://optn.transplant.hrsa.gov) 22 people on the National Transplant Waiting 
List die each day, while one person is added to the waiting list every 10 min. 
Additionally, people fortunate enough to receive an organ transplantation have 
to suffer from the lifelong use of immunosuppressants against chronic rejection. 
Therefore, new technologies are eagerly needed to create a transplantable liver [5]. 
Tissue engineering is a mixed field that aims to fabricate functional organs in vitro 
[6]. Over the decades, great progress has been achieved in the laboratory, and 
even some livers have been used in clinics [7]. Tissue engineering by using a decel-
lularization/recellularization strategy, which maintains the architecture, vascular 
system, and ECM components, has been shown to be a promising tool for solid 
organs, such as liver.
Liver tissue engineering by using decellularization/recellularization strategy 
(Figure 1) involves biomimicking the architecture and physiological features of 
the native liver. The procedure generally needs three major components: a scaf-
folding platform, seed cells, and a 3D microenvironment. Despite the numerous 
advances over the years, it is still an enormous challenge to fabricate a liver organ 
[8]. Generating liver organ-specific 3D structure scaffold to keep as much as 
original biochemical, physiochemical, and biomechanical ECM microenvironment 
is the one of the main hurdles in liver engineering field [9]. Such physiological 3D 
structure also plays a remarkable role in influencing seeded cell long-term survival 
and complex liver tissue mass formation [10]. To achieve this, scientists have been 
working with different scaffolding systems for liver tissue engineering. Studies have 
shown that a construction strategy based on a combination of a decellularized naïve 
liver matrix and recellularization with seed cells has led to constructs that match 
human organs in size and structure. However, the present constructs still only fulfill 
Figure 1. 
The decellularization/recellularization strategy in liver tissue engineering. Mammals donor-derived livers 
undergo a process of decellularization to obtain decellularized liver scaffolds (DLS) (step a–c), and then 
recellularized seed cells are placed onto the scaffolds (step d–f). Finally, the recellularized scaffolds are placed 
into 3D culture conditions in a bioreactor to construct liver-like tissues or organs with an overall structure and 
vasculature (step g).
3Optimization of a Decellularization/Recellularization Strategy for Transplantable Bioengineered...
DOI: http://dx.doi.org/10.5772/intechopen.89493
partial functions of the liver. The preservation of a functional ECM during decel-
lularization, cellular differentiation [11], and a lack of endothelial-lying vascular 
networks limits the long-term functional integration of constructs after in vivo 
transplantation. As techniques continue develop, some methods with the potential 
to overcome these challenges should be explored in the near future, which will fur-
ther boost the development of a tissue-engineered liver with improved functions. 
In this chapter, we have tried to focus on the possibility of liver tissue engineering 
by using a decellularization/recellularization strategy and to describe the current 
advancements made in the field to address a possible clinical transplantation.
2. Decellularization-based scaffold biomaterials
The term “biomaterials” traditionally means a nonliving substance used for 
a medical purpose. As the technology of biomaterials developed, the definition 
expanded to include substances to control the biological environment of cells and 
tissues for increased compatibility with a host to allow for colonization, prolifera-
tion, and differentiation of cells while maintaining their specific morphologies, 
configurations and avoiding immunological rejection. Based on the increasing 
knowledge of ECM biology, scaffold biomaterials can be grouped as synthetic 
materials, natural materials, or a decellularized matrix [12]. Moreover, modifica-
tions have been made to enhance the biologically active signals of scaffolds, leading 
to improved cell attachment, survival, and tissue formation [13, 14].
Biomaterials with required properties have been well studied from synthetic 
materials. For instance, a nanofibrous matrix made of poly and poly-embedded 
growth factors was transplanted into animals and restored cardiac regeneration 
by promoting vascularization [15]. Zawaneh et al. have reported the design of an 
injectable synthetic and biodegradable polymeric biomaterial consisting of poly-
ethylene glycol and a polycarbonate of dihydroxyacetone that is easily extruded 
through narrow-gage needles, biodegrades into inert products, and is well tolerated 
by soft tissues [16]. Those chemically and biologically modified synthetic materi-
als could result in a better way to mimic and control seed cell responses [17, 18]. 
Another advantage of synthetic materials is their easier to predict and control the 
degradation of synthetic scaffolds. However, despite this wealth of knowledge, the 
ability of synthetic biomaterials to support cell attachment, or induce phenotypic 
expression is much lower than that of natural biomaterials [19–21]; thus, natural 
biomaterials have been extensively studied [22].
Natural biomaterials include collagen, alginate, and chitosan. These types of 
biomaterials are inherently able to facilitate for seed cell attachment, proliferation, 
and functional differentiation, thus they hold significant promise for liver tissue 
engineering [23, 24]. However, traditional natural materials have poor inherent 
bioactivity, acidic byproducts, etc., and alone cannot rebuild the complex architec-
ture of solid organs like liver. Other limitations include their unpredictable degrada-
tion kinetics; generally, weak mechanical strength, and risk of evoking an immune 
response [25], etc. also need to be considered.
Decellularized scaffolds (matrices) being natural biomaterials, which are 
deprived of cellular components while maintaining their original architecture and 
vascular system, have been widely studied and used in more complex tissue engi-
neering [26]. In the case of liver tissue engineering, the use of decellularization/
recellularization strategy was inspired by a pioneer study of heart tissue engineer-
ing from the Ott group in 2008 [27]. After that, liver tissue engineered by using 
this approach has been fabricated [28–30]. Compared to those derived from other 
synthetic or natural biomaterial scaffolds, the decellularized liver scaffold (DLS) 
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mostly preserves the native complex liver ECM components, spatial microstruc-
ture, and perusable vascular architecture [31, 32] as more “biocompatible ways” 
for seed cells attaching and reorganizing on a complex 3D level [33]. Therefore, the 
DLS might have more favorable advantages than other scaffolds for clinical appli-
cation although the biocompatibility signal between ECM of the DLS and seed 
cells is still unclear. Scientists have recellularized stem cells onto the natural 3D 
DLS and have found that these culturing cells not only survive better in the scaf-
fold structure than their culturing in 2D environment but also differentiate into 
functional cells as well [34]. Zhang et al. seeded adult mouse liver hepatic stem/
progenitor cells onto the DLS that generated from naïve liver (nDLS) and cultured 
the complex in bioreactor, which formed a liver-like construction. Importantly, 
the nDLS/cell construction was able to repair a cirrhotic liver and even replace the 
failure liver [35].
Although many studies have been performed in the DLS field for liver tissue 
engineering [36–40], unfortunately, because of the nDLS being a lack of “active 
microenvironmental” support in existing ECM components, the optimization 
of the nDLS biomaterials become an important procedure for improving the 
skill of liver tissue engineering. Many protocols have been applied to modify the 
non-bioactive decellularized scaffolds. The application of a variety of growth 
factors [41] to promote the survival, proliferation, and differentiation of cells, like 
insulin-like growth factor 1 thought to promote hepatic cell differentiation from 
bone marrow-derived mesenchymal stem cells, vascular endothelial growth fac-
tor applied to enhance the vascularization of tissue-engineered tissues or organs. 
Additionally, the complex synergistic and antagonistic actions between different 
kinds of growth factors in vivo, more attention should be paid to the combined and 
sequential application of different growth factors. Consideration of optimizing the 
ECM of nDLS foir its behave like “naïve liver regenerative niche” might be a nice 
way to induce liver-like tissue formation spontaneously both in vitro and in vivo. 
Based on this, recently, Yang et al. has presented a very interesting experiment: 
the authors generated an acellular liver scaffold from pretreated naïve liver. They 
pretreated a naïve liver by performing a 30–55% partial hepatectomy, and the 
liver was maintained in vivo for 3–5 days until acute liver regeneration occurred, 
which allowed for the generation of the scaffold from the regenerative liver (rDLS) 
(Figure 2). These rDLS retain a variety of higher level of supporting growth factors 
for liver spontaneous regeneration as compared to that of nDLS, including their 
collagens, growth factors (HGF, TGF-α, IL-6, b-FGF, VEGF), glycosaminoglycans, 
antithrombotic proteins, and other matrix proteins [42]. Since the novel rDLS pos-
sesses a natural liver regenerative microenvironment, so-called “bioactive” ECM, 
it has shown more efficiency than nDLS in promoting primary hepatocyte survival 
and antithrombotic activity. Notably, when recellularized the rDLS with intrahe-
patic stem/progenitor cells and cultured them in 3D environment, a more likely 
liver organ was formatted as compared to the nDLS recellularized with the same 
stem/progenitor cells, after transplanted into recipients [42]. This pioneer study 
demonstrated that “bioactive” scaffolds of the rDLS obtained from a regenerative 
liver possess an advanced natural “active state niche” as compared to nDLS (“still 
state niche”) for promoting primary hepatocyte survival, resistance to thrombosis, 
and liver-like organ construction. Other forms of bioactive factors are also involved 
in liver tissue engineering, like microRNAs, etc. [43, 44]. Furthermore, it needs to 
be mentioned that the advantage of highly conserved each specific ECM protein of 
decellularized scaffold among species of which the ECM are recognizable within 
and between species largely without immune rejection [45, 46] when properly pro-
cessed to remove cellular antigens that would induce an immune rejection without 
damaging the ECM.
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3.  Seed cells response to the natural three-dimensional-decellularized 
liver biomaterial scaffold
Cellular components are an integral part of any tissue engineering. In the case of 
the liver, it is important to find appropriate cells, such as hepatocytes or stem cells 
and to seed them into biomaterial scaffolds to regenerate liver tissues or organs [47]. 
Appropriate seed cells contain parenchymal such as hepatocytes, cholangiocytes, and 
supportive cells like liver sinusoidal endothelial cells, Kupffer cells, hepatic stellate 
cells, and pit cells [48]. Hepatocytes account for 60–65% of a liver’s cell population [1, 
2, 49], which is important for liver tissue engineering. If it is difficult to obtain patient-
derived hepatocytes, along with challenging isolation, culture, and the low yields of 
these cells in vitro [50], stem cells are required for liver tissue engineering [51, 52].
Stem cells are generally grouped as embryonic stem cells (ESCs), somatic stem 
cells (SSCs), and inducible pluripotent stem cells (iPS) [53]. ESCs have a higher 
regenerative capacity and can be manipulated to differentiate into other cell types 
[54, 55]. For liver tissue engineering, ESCs are considered beneficial for the pur-
pose of cell differentiation. For instance, epithelial cells differentiate from ESCs, 
which could cover the interior of vessels (arteries, veins, and capillaries) of DLS, 
and the interior of vessels is one of the major players of the angiogenesis process in 
physiological and pathological conditions involved in thrombus resistant effects. 
Due to the ethical problems with ESCs, tetratomics and expanded adult human 
hepatocytes [56], iPS are described as an alternative for adult human hepatocyte 
differentiation [57–61]. More studies about iPS are under active investigation at 
present [62], but dozens of publications regarding iPS-derived hepatic lineages have 
varied from report to report, making it difficult to compare the relative successes 
of the various modified protocols in enhancing hepatocyte differentiation [63, 64]. 
Moreover, cultured human hepatocytes often upregulate inappropriate immature 
markers, such as alpha-fetal protein (AFP). Consequently, any comparisons made 
to these altered adult hepatocytes may make the candidate immaturely appear 
more strongly functional than they truly are. Indeed, an examination of published 
accounts reveals that many protocols lead to fetal hepatocyte-like cells, but in some 
Figure 2. 
Generation of a porcine decellularized liver scaffold from naïve livers and livers that had undergone partial 
hepatectomy (PHx). (A) Perfusion procedure for liver organ decellularization. (B) Blood-vessel tree of a 
decellularized scaffold from a naïve liver (nDLS). (C) Blood vessel tree of a decellularized scaffold from a 
partial hepatectomy (PHx) liver (rDLS).
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cases, the characterization reported is not sufficient to determine the fetal versus 
mature nature of the resulting differentiated hepatic cells. Given the seemingly fetal 
nature of iPS-derived hepatic cells produced to date, it is apparent that additional, 
careful modification of differentiation protocols is still required for further inves-
tigation before clinical implementation. Somatic stem cells could overcome the 
obstacles caused by ECSs, thereby making them more appropriate for liver tissue 
engineering [65, 66].
SSCs are composed of intrahepatic SSCs and extrahepatic SSCs. Bone mar-
row-, umbilical-, and fat tissue-derived mesenchymal stem cells are well accepted 
extrahepatic SSCs [67–69], while oval cells, especially neuro-glial antigen 2 (Ng2)-
expressing cells (Ng2+HSP), are currently identified as intrahepatic stem/progeni-
tor cells. Isolation of the Ng2+HSP should be completed by using a specific protocol 
[70]. Other sources of SSC behaviors seeded in the DLS have also influenced liver 
tissue engineering. Several studies have demonstrated that liver-derived mesenchy-
mal stem cell (MSC)-like cells can differentiate into hepatocytes and cholangiocytes 
in nDLS and that the functional differentiation of MSCs in certain situations could 
be an alternative approach for an engineered liver organ transplantation in the 
treatment or replacement of ESLD [35, 71]. Our recently studied animal models 
have revealed that intrahepatic MSC-like SSCs repaired injured livers better than 
extrahepatic MSCs [unpublished]. Contrary to past hypotheses, extrahepatic bone 
marrow-derived MSCs do not seem to directly differentiate themselves into hepato-
cytes, in particularly in vivo, compared to local (liver) MSC-like cells, such as above 
mentioned the Ng2+HSP. As the Ng2+HSP has been demonstrated to have a role in 
tissue repair [70] and failed liver replacement [35] in liver cirrhosis murine model, 
we recently further demonstrated that the intrahepatic Ng2+HSP cells are capable 
of more efficiency than extrahepatic BM-MSCs in self-renewal and hepatocyte and 
cholangiocyte differentiations (unpublished) (Figure 3). Interestingly, by using 
the Ng2+HSP, Zhang et al. have successfully reconstituted a liver construct in vitro 
Figure 3. 
Murine intrahepatic and extrahepatic mesenchymal stem cells (MSCs). (A) Cultured and 
immunofluorescently stained of intrahepatic neuro-glial antigen 2 (Ng2)-expressing mesenchymal stem cell 
(MSC)-like stem/progenitor cells (Ng2+HSP). (B) Cultured and immunofluorescently stained identical bone 
marrow (BM)-derived-MSCs (BM-MSCs), as visualized by optical microscopy, scale bar = 100 μM.
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that is very similar to a naïve liver organ [35]. In addition, the immuno-modulatory, 
anti-inflammatory, antiapoptotic, and angiogenic properties of the intrahepatic 
MSC-like Ng2+HSP in the liver still need to be further investigated for liver tissue 
engineering.
4. Decellularization/recellularization strategy-based liver construction
With the development of decellularization approaches, such as the detergent 
perfusion technique, whole decellularized scaffolds from liver organs have been 
produced DLS with an ECM structure and bioactive components being used 
fabricate bioengineered liver tissues, thus serving as a platform for liver organ 
bioengineering. Within the past several decades, numerous accomplishments 
have been driven by the development of these construction strategies. To date, 
decellularization-based liver construction strategies are constantly advancing such 
as maintaining complete hepatic vessel networks [72].
Despite the well-conserved macroscopic structure of a liver organ obtained by 
using decellularization, it is still difficult to avoid some disruption to the ECM com-
position and ultrastructure through decellularization, which leads to impairment 
of the natural 3D microenvironment, for example, an impairment of glycosami-
noglycans within the ECM by enzymes [73] can cause altered stiffness. Therefore, 
improved measures for preserving the integrity of the ECM during the decellular-
ization process are required [74, 75]. An functional engineered liver tissue usually 
uses stem cells or progenitor cells that need to differentiate into multiple kinds of 
repair cells, which is a challenge to directly seed cells to colonize in relevant sites of 
DLS to induce their differentiation into specific cell types. Whether an engineer-
ing formed liver organ can successfully fulfill its functions depends not only on its 
physically decellularized scaffold structure but also on an effective recellularization. 
Therefore, how to populate seed cells like differentiated hepatocytes from different 
kinds of seed cells or stem cells themselves onto the DLS needs to be carefully con-
sidered. In particular, how to manipulate the DLS to enhance the targeted specific 
colonization of cells to specific areas of DLS such as perfused endothelial cells 
[76–78], has drawn much attention. To ensure the long-term survival of an engi-
neered liver by allowing exchanges of oxygen, nutrients, and disposal of metabolic 
waste [79], a functional vascular network and thrombosis after transplantation also 
needs to be considered. Despite the conservation of the general vascular structure 
by DLS, the formation of a functional vascular network remains a challenge for liver 
organ construction. The mainstream strategy to fabricate an engineered liver organ 
with a functional vascular network includes also the procedure of prevasculariza-
tion. The initial approaches have been successfully used in spontaneous lineage of 
endothelial cells in DLS vascular networks after recellularization with stem cells 
[80–82] to challenge thrombosis after transplantation when exposed to blood, thus 
leading to localized organ failures [83]. There are two nice approaches showed that 
endothelialization of vasculature and immobilization of heparin on nDLS could 
reduce its incidence of thrombosis [84]. More recently, from a pretreated naïve liver 
obtained rDLS, exhibited except for strong promoting primary hepatocyte survival 
but also antithrombosis more effect [biomaterials 2018]. Notably, after transplanta-
tion guiding the rDLS/cells complex forms complex liver-like tissues (geometries) 
more effective on rDLS than on nDLS (Figure 4), meanwhile combined with better 
organization of endothelial lineage in rDLS than in nDLS [42]. This suggests that 
rDLS possesses an advanced “bioactive natural regeneration state niche” relative to 
the nDLS, which preserves a “still state niche.” Therefore, the spontaneous manipu-
lation of the ECM on DLS is a more promising strategy for decellularization-based 
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liver tissue. In the future, the objective of a decellularization-based liver construc-
tion strategy could be based on generating a 3D decellularized biomaterial scaffold 
with natural “regenerative bioactive niche” for the seed cell attachment, prolifera-
tion and differentiation of cells, and developing a transplantable “new” liver in vitro 
that maintains the structures and functions of a naïve liver.
In summary, compared with other strategies that can only fabricate partial 
structures, a decellularization/recellularization-based liver tissue engineering 
strategy enables the construction of the liver structures with complete blood vessel 
network at a clinically relevant scale, thus becoming a more promising approach 
for liver tissue engineering. However, in order to provide a promising route for 
developing a functional bioartificial liver with potential applications for humans by 
Figure 4. 
Comparison of the murine liver-lobule-like tissue construction formation between rDLS and nDLS after 
portal-renal arterialized auxiliary heterotopic liver transplantation. (A) Schematic of the procedure. The 
left green cycle indicates the DLS, and the right green cycle indicates the end-to-end anastomosis of the PV 
(scaffold)-L-RA (recipient). The green arrows in the panels indicate the right-RA. The right bottom cartoon 
shows the end-to-side anastomosis of the IVC (scaffold)-IVC (recipient). (Ba–d) Exposure of the right-side 
kidney (the square indicates the kidney) (a). Nephrectomy of the right-side kidney (the square indicates the 
lack of kidney) (b). The cell-loaded DLS where the kidney was removed (the bold arrow indicates the PV, 
thin arrow indicates the IVC, and the green arrow indicates a right renal artery (right-RA)). The left-side 
renal artery (L-RA) was connected to the PV with cross-clamping of the PV and the IVC of the recellularized 
scaffold (c). The noncell loaded DLS was connected to the recipient by the same procedure as the cell-loaded 
DLS where the kidney was removed (d). (Ca–c) DLS seeded with Ng2+HSP cells formed a liver-lobule-like 
construct in rDLS (a and b) after approximately 20–40 days (a, indicated as a cycle), for two lobes with better 
blood patency (b), represented with a white arrow; there was no visible blood flow in the nDLS loaded with 
Ng2+HSP cells for the same time (c). (D) Blood flow velocity (flow, arbitrary unit, AU) was measured in rDLS 
and nDLS at 45 min within 100 s after the operation by a near-infrared-LDF system, scale bar = 50 μM.
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such strategy, several questions must be answered: (1) Is the use of a decellularized 
liver matrix the only possible solution? (2) What kinds of cells need to be chosen for 
recellularization? Extrahepatic cells? or possibly resident stem/progenitors cells? 
(3) What is the optimal decellularized liver scaffold (DLS)? (4) What is the length 
of time for incubation in a bioreactor? (5) Would the technique be applicable to a 
human liver with its extensively sinusoidal surface?
5. Conclusion and challenges
Clearly, decellularization/recellularization through the development of in vitro 
and in vivo tissue and organ models for liver bioengineering are advancing strate-
gies. This, combined with multidisciplinary team-workers performing focused, 
systematic studies to address critical questions, is essential for the success of this 
strategy. The following critical issues might need to be addressed before clinical 
applications: (1) preservation and modification of a functional ECM structure to 
better mimic the regenerative niche; (2) selection of effective seed cell sources for 
recellularization; (3) modification of blood-vessel networks for “endothelialized 
DLS”; (4) long-term survival by preventing from thrombosis and functions after 
transplantation; and (5) immune rejection. In the coming years, many new tech-
niques will be explored, which are expected to have the potential to address these 
challenges.
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